Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE +0.1%, DAX (0.3%), CAC (0.4%), MIB (0.2%), IBEX (0.2%)

Sep 14 ,2026

  • Synopsis

    • European equity markets are set to open mostly lower, with the UK's FTSE 100 indicated marginally higher. Recall that last week, STOXX Europe 600 saw a weekly loss of (1.66%). European equity markets were lower for the second consecutive week. Firmer energy prices and a backdrop in bond yields remained a headwind for regional markets, though some signs of stabilization on Friday saw markets end the week on steadier footing. Health Care was the weakest sector overall, largely reflecting heavy pressure on Novartis (NOVN.SW) (13.5%) following two late-stage clinical setbacks.

    • Asian equities mixed Monday. Tech-heavy benchmarks in Japan, South Korea and Taiwan under the most pressure though off worst levels. AI trade under pressure after Anthropic CEO Amodei called for slowing development of AI models amid safety concerns.

    • Oil sharply higher following weekend Middle East developments. Lot of focus on Houthi capture of strategic locations along Yemen's southern coast, giving it leverage over Bab el-Mandeb Strait in risk to shipping. Saudi Arabia shut East-West pipeline due to damage from drone strike. Planned meeting between Iran and Gulf foreign ministers on Monday to discuss Strait of Hormuz management postponed amid lack of consensus (recall news of meeting was attributed for Friday's pullback in oil).

    • Markets bracing for an eventful week headlined by key central bank decisions. Fed (Wed) expected to hike by 25 bp following Friday's CPI data that showed pickup in core inflation. BOE (Thurs) with no change expected in the 3.75% benchmark interest rate. BOJ (Fri) also expected to tighten by 25 bp with more interest surrounding prospect of central bank quickening pace of rate hikes amid inflation and yen concerns.

    • Also on this week's agenda: Eurogroup meeting, EU State of the Union address, UK Aug employment and inflation data, Germany Sep economic sentiment - ZEW, Switzerland Aug trade balance as well as earnings/updates from Barratt Redrow (BTRW.LN), Bolloré (BOL.FP), Helvetia Baloise Holding (HBAN.SW) and Next (NXT.LN).

    • European macro data releases out today include Switzerland Aug PPI, Sweden Aug final CPI, Finland Aug CPI

    • In central banks today, ECB publishes at 10:00CET the aggregate results of its latest survey of monetary analysts. ECB's Schnabel speech at 11:15CET at the Federal Ministry for Economic Affairs and Energy (BMWE) Symposium on European Competitiveness, ECB's Cipollone speech at 15:00CET at an event at House of the Euro, ECB's Lagarde speech/panellist from 17:15CET at event 'Hofburg im Dialog - Economy, Europe, Resilience' and ECB's Machado fireside chat at 18:00CET at Barclays Global Financial Services conf. Also, BOE's Wilkins speech at 17:30BST at Queens Univ. Bank of Italy hosts EPSI conf (through Tue). Bank of Finland will host the 12th Workshop of the MPC Taskforce on Banking Analysis for Monetary Policy (through Tue).

    • In Sweden, the general election was reported too close to call early Monday, as the incumbent prime minister and the left-wing opposition leader both said they were ready to govern and the far right was seen losing ground. With 94% of votes reported, the left-wing bloc led by the Social Democrats was ahead with 176 mandates compared to the right-wing bloc's 173. (AFP, BBC)

  • Macro/politics

    • UK

      • PM Burnham to meet business leaders to discuss growth (Reuters )

      • Oil price surge revives prospect of Bank of England rate rise this year (FT)

    • ECB

      • European capitals barter over Christine Lagarde's successor at ECB (FT )

    • Sweden

      • Nordic region's biggest economy faces weeks of uncertainty and tricky government negotiations (FT)

    • France

      • Bank of France Issues Statement on Debt Amid 'False' Information (BBG)

      • Roland Lescure, France's economy minister, seeking to restore budgetary room for manoeuvre (Le Parisien )

  • Top company news

    • Earnings/updates

      • VEND.NO (Vend Marketplaces) -- reports Q3 pre-silent newsletter

      • ISS.DC (ISS A/S) -- to present new mid-term financial targets at Capital Markets Day

      • KESKOB.FH (Kesko) -- reports Aug sales €1.17B, +4.8% in comparable terms

      • Also reporting today

        • Earnings:

          • Ireland: Greencoat Renewables (GRP.ID)

          • Southern Europe: SeSa (SES.IM), NewPrinces (NWL.IM), Gas Plus (GSP.IM)

          • UK: HgCapital Trust (HGT.LN), M.P. Evans Group (MPE.LN), RTW Biotech Opportunities (RTW.LN), GlobalData (DATA.LN), Big Technologies (BIG.LN), Keystone Law Group (KEYS.LN), Pantheon Resources (PANR.LN)

        • CMD/Events: ISS (ISS.DC), IPS.FP (Ipsos) exec. update call

    • M&A

      • AZN.LN (AstraZeneca) -- not pursuing megadeals - London Times

      • TIT.IM (Telecom Italia) -- Poste Italiane announces preliminary result of offer for Telecom Italia (post EU close 11-Sep)

      • SYS1.LN (System1 Group) -- 28% holder Brave Bison to put in new £50M offer for System1 Group this week - Sunday Times

      • TRB.LN (Tribal Group) -- announces proposed acquisition by Main Capital Partners for c. £189.3M

      • CAP.FP (Capgemini) -- signs a definitive agreement to sell Government Solutions

      • ENX.FP (Euronext) -- willing to merge with Deutche Börse - FT

      • REC.IM (Recordati) -- holders unhappy with CVC's take-private bid - FT

      • EQT.SS (EQT AB) -- EU clears EQT's acquisition of Exolaunch

      • SDR.LN (Schroders) -- looking at acquisitions to boost its wealth division - FT

      • CWY.AU (Cleanaway Waste Management) -- notes EQT is continuing due diligence and working towards negotiation and execution of an implementation deed

      • NOL.NO (Northern Ocean) -- Northern Ocean announces final result of mandatory offer

      • Bank of Italy authorizes Banca CF+ and Banca Sistema merger (post EU close 11-Sep)

      • Banca Sistema shareholders to vote on 12-Oct on merger with Banca CF+ (post EU close 11-Sep)

      • Tandem Health raises $100M led by the Scaleup Europe Fund managed by EQT

      • EU clears Allianz's, via Pacific Investment Management Co, acquisition of Ingenico Group

    • Healthcare

      • JNJ (Johnson & Johnson) -- presents results from OS analysis of PAPILLON study of RYBREVANT at WCLC

      • AZN.LN (AstraZeneca) -- provides update on SERENA-4 Phase III trial; Etcamah (camizestrant) in combination with palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, did not meet the primary endpoint of progression-free survival (PFS)

      • AZN.LN (AstraZeneca) -- 's ADAURA phase III trial demonstrates eight-year landmark survival in early-stage EGFR-mutated lung cancer

      • AZN.LN (AstraZeneca) -- reports positive results from DESTINY-Lung04 Phase III trial presented at the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer

      • ROP.SW (Roche Holding) -- Medilink presents, publishes data from TAISHAN-302 trial of Tam-Peli

      • ARAY (Accuray) -- and RaySearch agree to collaboration integrating RayStation software with Platforms

      • ALCLS.FP (Cellectis SA) -- to host conference call and webcast on 14-Sep to provide a business update

      • PHARM.NA (Pharming Group) -- FDA approves Pharming Group's Joenja (leniolisib) for the treatment of children aged 4-11 years with activated phosphoinositide 3-kinase delta syndrome

      • PHARM.NA (Pharming Group) -- Follow-up: Pharming confirms FDA approval of Joenja as first treatment for children with APDS in the U.S.

    • Other

      • OR.FP (L'Oreal) -- Arizona Attorney General's Office files consumer fraud lawsuit against L'Oréal USA

      • GLEN.LN (Glencore) -- and Mercuria in talks with the Government of Venezuela to secure rights to the country's largest aluminum smelter - Bloomberg

      • IAG.LN (International Consolidated Airlines Group) -- completes €500M share buyback program

      • LGEN.LN (Legal & General Group) -- completes first £600M tranche of £1.2B share buyback program

      • 1COV.GR (Covestro) -- Covestro, Fertiglobe and MB Energy sign MoU to explore ammonia supply chain in Germany and Europe

      • DOCM.SW (DocMorris) -- announces final conversion price and issue size of its new convertible bonds due 2031

      • Estimated weekend box office revenues in US, Canada $81.7M, (44.6%) y/y - Box Office Mojo

      • UAE's Adnoc commits €40B in long-term capital into Germany's core industries - Gas World

      • WPP positioned to win Coca-Cola's global agency review following Publicis Groupe's exit from the process - AdAge

  • Key rating changes

    • Upgrades

      • ANTO.LN (Antofagasta) -- to buy from hold at Berenberg

      • FLS.DC (FLSmidth & Co.) -- to buy from hold at DNB Carnegie

      • FORTUM.FH (Fortum) -- to hold from sell at Deutsche Bank

      • CPR.IM (Campari) -- to buy from neutral at UBS

  • Data

    • Nikkei (0.91%) to 63425.84

    • Hang Seng +0.37% to 24896.64

    • Shanghai Composite (0.17%) to 3881.32

    • S&P futures (44.0) vs prior close of 7659.5

    • €-$ (0.0030) or (0.26%) to 1.1570

    • $-¥ +0.46 or +0.30% to 154.05

    • €-¥ +0.08 or +0.04% to 178.22

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.